Name
PLENARY 2 - State of the Art: Report Card on Drug Development for HBV: Lessons Learned and the Path Forward
Date & Time
Wednesday, March 19, 2025, 10:30 AM - 12:00 PM
Speakers
Ronald Alcalá, Inserm UMR 1350 - PaThLiv
Edward Gane, University pf Auckland
Funmi Lesi, World Health Organization
Seng Gee Lim, National University Health System
Edward Gane, University pf Auckland
Funmi Lesi, World Health Organization
Seng Gee Lim, National University Health System
Description
- Report Card on Drug Development for HBV: Lessons Learned and the Path Forward + Q&A Ed Gane
- Oral Presentation: ANTI-HBSAG MONOCLONAL ANTIBODY BJT-778 DEMONSTRATES PANGENOTYPIC NEUTRALIZATION OF HEPATITIS B AND D VIRUSES + Q&A Ronald Alcala
- Oral Presentation: HBSAG LOSS IN INACTIVE CHRONIC HEPATITIS B CARRIERS IS DEPENDENT ON LEVEL OF QHBSAG AND INTERFERON RESPONSE: A RANDOMISED CONTROL TRIAL + Q&A Seng Gee Lim
- Introductory Talk: Current & future therapies from a global perspective (challenges & barriers) Funmi Lesi
- Panel - HBV Therapeutics (what's needed now and in the future) + Q&A